Artificial Intelligence, Radiomics, and Deep Learning in Neuro-Oncology

Norbert Galldiks,Gelareh Zadeh,Philipp Lohmann
DOI: https://doi.org/10.1093/noajnl/vdaa179
2020-12-01
Abstract:Besides the histomolecular evaluation of tissue samples obtained from resection or biopsy, neuroimaging forms the basis for the diagnosis of brain cancer. Contrast-enhanced MRI is the method of choice for brain tumor diagnostics, treatment planning, and follow-up. Currently, advanced MRI techniques as well as amino acid PET are increasingly applied, generating a large variety of imaging parameters for brain tumor diagnostics. This is also driven by the increasing availability of hybrid PET/CT and PET/MRI scanners. Evaluation of the complex, multiparametric imaging data can be achieved by methods from the emerging field of artificial intelligence, potentially supporting physicians in clinical routine. For example, time-consuming steps such as manual detection and segmentation of lesions can be performed fully automatically. Since computer-aided image analysis is independent of the experience level of the evaluating physician, the results are more standardized and improve the inter-institutional comparability.
What problem does this paper attempt to address?